Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	growth factor binding	ERBB3 IGF1R IGFBP3 EGFR WFIKKN1 INSR KAZALD1 TWSG1	1.71e-07	156	78	8	GO:0019838
GeneOntologyMolecularFunction	extracellular matrix structural constituent	RELN FBLN2 VWF LAMA2 LAMA4 TECTA ZP3 SSPOP	7.10e-07	188	78	8	GO:0005201
GeneOntologyMolecularFunction	insulin-like growth factor binding	IGF1R IGFBP3 INSR KAZALD1	7.99e-07	19	78	4	GO:0005520
GeneOntologyMolecularFunction	cargo receptor activity	SCARF1 LRP12 INSR ITGB2 EGFEM1P STAB1	1.00e-06	85	78	6	GO:0038024
GeneOntologyMolecularFunction	integrin binding	ITGBL1 VWF EGFR ITGB2 ITGB5 ITGB6 SVEP1	5.51e-06	175	78	7	GO:0005178
GeneOntologyMolecularFunction	alpha-L-arabinofuranosidase activity	OTOGL OTOG	1.51e-05	2	78	2	GO:0046556
GeneOntologyMolecularFunction	insulin-like growth factor I binding	IGF1R IGFBP3 INSR	1.59e-05	13	78	3	GO:0031994
GeneOntologyMolecularFunction	insulin receptor activity	IGF1R INSR	4.51e-05	3	78	2	GO:0005009
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	ERBB3 IGF1R EGFR INSR	1.22e-04	65	78	4	GO:0004714
GeneOntologyMolecularFunction	insulin binding	IGF1R INSR	1.49e-04	5	78	2	GO:0043559
GeneOntologyMolecularFunction	scavenger receptor activity	SCARF1 EGFEM1P STAB1	1.57e-04	27	78	3	GO:0005044
GeneOntologyMolecularFunction	structural molecule activity	RELN FBLN2 IGF1R VWF INSR LAMA2 LAMA4 KRTAP29-1 TECTA ZP3 SSPOP OTOG	1.66e-04	891	78	12	GO:0005198
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	ERBB3 IGF1R EGFR INSR	3.43e-04	85	78	4	GO:0019199
GeneOntologyMolecularFunction	insulin-like growth factor II binding	IGFBP3 INSR	4.15e-04	8	78	2	GO:0031995
GeneOntologyMolecularFunction	insulin receptor substrate binding	IGF1R INSR	1.53e-03	15	78	2	GO:0043560
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	LRP12 STAB1	1.74e-03	16	78	2	GO:0005041
GeneOntologyMolecularFunction	low-density lipoprotein particle binding	SCARF1 STAB1	2.21e-03	18	78	2	GO:0030169
GeneOntologyMolecularFunction	protein tyrosine kinase activity	ERBB3 IGF1R EGFR INSR	2.51e-03	145	78	4	GO:0004713
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	LRP12 STAB1	3.01e-03	21	78	2	GO:0030228
GeneOntologyMolecularFunction	protein-hormone receptor activity	IGF1R INSR	3.31e-03	22	78	2	GO:0016500
GeneOntologyMolecularFunction	virus receptor activity	EGFR ITGB5 ITGB6	4.50e-03	85	78	3	GO:0001618
GeneOntologyMolecularFunction	transforming growth factor beta binding	WFIKKN1 TWSG1	4.61e-03	26	78	2	GO:0050431
GeneOntologyMolecularFunction	exogenous protein binding	EGFR ITGB5 ITGB6	4.65e-03	86	78	3	GO:0140272
GeneOntologyBiologicalProcess	arabinose metabolic process	OTOGL OTOG	1.34e-05	2	76	2	GO:0019566
GeneOntologyBiologicalProcess	vibrational conductance of sound to the inner ear	OTOGL OTOG	1.34e-05	2	76	2	GO:0055127
GeneOntologyBiologicalProcess	L-arabinose metabolic process	OTOGL OTOG	1.34e-05	2	76	2	GO:0046373
GeneOntologyBiologicalProcess	exocrine system development	IGF1R EGFR INSR TWSG1	5.80e-05	57	76	4	GO:0035272
GeneOntologyBiologicalProcess	peptidyl-tyrosine autophosphorylation	IGF1R EGFR INSR	7.04e-05	22	76	3	GO:0038083
GeneOntologyBiologicalProcess	integrin-mediated signaling pathway	ITGBL1 LAMA2 ITGB2 ITGB5 ITGB6	9.51e-05	124	76	5	GO:0007229
GeneOntologyBiologicalProcess	cell-substrate adhesion	ITGBL1 FBLN2 VWF TECTA ITGB2 ITGB5 ITGB6 SVEP1	1.32e-04	410	76	8	GO:0031589
GeneOntologyBiologicalProcess	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	ERBB3 RELN IGF1R EGFR INSR PDGFC	1.50e-04	217	76	6	GO:0051897
GeneOntologyBiologicalProcess	molting cycle	KRTAP4-1 EGFR KRTAP4-3 KRTAP4-8 KRTAP4-9	2.32e-04	150	76	5	GO:0042303
GeneOntologyBiologicalProcess	hair cycle	KRTAP4-1 EGFR KRTAP4-3 KRTAP4-8 KRTAP4-9	2.32e-04	150	76	5	GO:0042633
GeneOntologyCellularComponent	keratin filament	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	1.36e-20	97	79	15	GO:0045095
GeneOntologyCellularComponent	intermediate filament	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	6.31e-15	227	79	15	GO:0005882
GeneOntologyCellularComponent	intermediate filament cytoskeleton	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	5.52e-14	263	79	15	GO:0045111
GeneOntologyCellularComponent	extracellular matrix	RELN FBLN2 FCGBP VWF MEGF6 OTOGL LAMA2 LAMA4 CRISP3 MUC5B KAZALD1 TECTA ZP3 SSPOP SVEP1 OTOG	2.54e-09	656	79	16	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	RELN FBLN2 FCGBP VWF MEGF6 OTOGL LAMA2 LAMA4 CRISP3 MUC5B KAZALD1 TECTA ZP3 SSPOP SVEP1 OTOG	2.65e-09	658	79	16	GO:0030312
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	1.16e-06	899	79	15	GO:0099513
GeneOntologyCellularComponent	protein complex involved in cell adhesion	ITGBL1 LAMA2 ITGB2 ITGB5 ITGB6	2.89e-06	59	79	5	GO:0098636
GeneOntologyCellularComponent	integrin complex	ITGBL1 ITGB2 ITGB5 ITGB6	6.27e-06	32	79	4	GO:0008305
GeneOntologyCellularComponent	supramolecular fiber	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	3.04e-05	1179	79	15	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	3.29e-05	1187	79	15	GO:0099081
GeneOntologyCellularComponent	plasma membrane protein complex	ITGBL1 ERBB3 IGF1R EGFR INSR C8B SLCO6A1 ITGB2 SSPOP ITGB5 ITGB6 CRB1	3.67e-05	785	79	12	GO:0098797
GeneOntologyCellularComponent	insulin receptor complex	IGF1R INSR	8.42e-05	4	79	2	GO:0005899
GeneOntologyCellularComponent	collagen-containing extracellular matrix	RELN FBLN2 VWF MEGF6 LAMA2 LAMA4 KAZALD1 ZP3 SSPOP	1.72e-04	530	79	9	GO:0062023
GeneOntologyCellularComponent	plasma membrane signaling receptor complex	ITGBL1 ERBB3 IGF1R INSR ITGB2 ITGB5 ITGB6	3.58e-04	350	79	7	GO:0098802
GeneOntologyCellularComponent	receptor complex	ITGBL1 ERBB3 IGF1R EGFR INSR ITGB2 ITGB5 ITGB6	1.57e-03	581	79	8	GO:0043235
MousePheno	abnormal tooth color	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 VWDE ITGB6	3.19e-12	40	57	8	MP:0013129
MousePheno	increased thigmotaxis	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9	1.55e-05	132	57	6	MP:0002797
MousePheno	abnormal craniofacial bone morphology	IGF1R KRTAP9-4 EGFR KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 LAMA2 KRTAP9-9 TWSG1 PDGFC VWDE ITGB6	2.13e-05	827	57	13	MP:0002116
MousePheno	increased kidney weight	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9	2.64e-05	145	57	6	MP:0003917
MousePheno	abnormal tooth morphology	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 VWDE ITGB6	4.11e-05	318	57	8	MP:0002100
MousePheno	abnormal dental arch morphology	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 VWDE ITGB6	4.21e-05	319	57	8	MP:0030254
MousePheno	abnormal jaw morphology	KRTAP9-4 EGFR KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 TWSG1 VWDE ITGB6	4.89e-05	530	57	10	MP:0000454
MousePheno	abnormal mouth morphology	KRTAP9-4 EGFR KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 TWSG1 PDGFC VWDE ITGB6	6.93e-05	670	57	11	MP:0000452
MousePheno	abnormal cranium morphology	IGF1R KRTAP9-4 EGFR KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 LAMA2 KRTAP9-9 TWSG1 VWDE ITGB6	8.63e-05	813	57	12	MP:0000438
MousePheno	abnormal viscerocranium morphology	KRTAP9-4 EGFR KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 TWSG1 VWDE ITGB6	1.25e-04	593	57	10	MP:0005274
MousePheno	loss of vibrissae	SCARF1 EGFR	1.62e-04	5	57	2	MP:0001280
MousePheno	abnormal axon radial sorting	LAMA2 LAMA4	1.62e-04	5	57	2	MP:0020452
MousePheno	enlarged thymus	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 ITGB6	1.75e-04	292	57	7	MP:0000709
MousePheno	abnormal kidney weight	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9	1.95e-04	208	57	6	MP:0002707
MousePheno	abnormal submandibular gland development	EGFR TWSG1	3.39e-04	7	57	2	MP:0013541
MousePheno	decreased Schwann cell number	ERBB3 LAMA4	4.50e-04	8	57	2	MP:0001107
MousePheno	abnormal Schwann cell morphology	ERBB3 LAMA2 LAMA4	4.53e-04	37	57	3	MP:0001106
MousePheno	abnormal PNS glial cell morphology	ERBB3 LAMA2 LAMA4	4.53e-04	37	57	3	MP:0001105
MousePheno	abnormal head morphology	CNNM2 KRTAP9-4 EGFR KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 BTAF1 TWSG1 PDGFC VWDE ITGB6	4.59e-04	1120	57	13	MP:0000432
MousePheno	abnormal somatic sensory system morphology	ERBB3 RELN IGF1R IGFBP3 EGFR LAMA2 TECTA MEGF11 CRB1 OTOG	4.84e-04	702	57	10	MP:0000959
MousePheno	abnormal axial skeleton morphology	IGF1R KRTAP9-4 EGFR KRTAP9-6 WFIKKN1 KRTAP9-2 KRTAP9-8 KRTAP9-3 LAMA2 KRTAP9-9 TWSG1 PDGFC SSPOP VWDE ITGB6	5.60e-04	1458	57	15	MP:0002114
Domain	KAP	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	9.22e-26	58	77	16	IPR002494
Domain	Keratin_B2_2	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9	1.63e-24	39	77	14	PF13885
Domain	Keratin_B2	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP4-6 KRTAP9-9 KRTAP4-9	2.50e-24	40	77	14	PF01500
Domain	EGF_1	SCARF1 ATRN ITGBL1 NELL2 RELN FBLN2 MEGF6 LAMA2 LAMA4 ADAM30 ADAM33 C8B ADAM32 ITGB2 SSPOP VWDE ITGB5 ITGB6 MEGF11 SVEP1 CRB1 STAB1	1.98e-23	255	77	22	PS00022
Domain	EGF-like_dom	SCARF1 ATRN ITGBL1 NELL2 RELN FBLN2 FCGBP MEGF6 LAMA2 LAMA4 ADAM30 ADAM33 C8B ADAM32 TECTA VWDE MEGF11 SVEP1 CRB1 OTOG STAB1	3.69e-22	249	77	21	IPR000742
Domain	EGF_2	SCARF1 ATRN ITGBL1 NELL2 RELN FBLN2 MEGF6 LAMA2 ADAM30 ADAM33 C8B ADAM32 ITGB2 SSPOP VWDE ITGB5 ITGB6 MEGF11 SVEP1 CRB1 STAB1	1.37e-21	265	77	21	PS01186
Domain	EGF_extracell	SCARF1 ATRN ITGBL1 NELL2 RELN MEGF6 ADAM33 ADAM32 ITGB2 ITGB5 ITGB6 MEGF11 SVEP1 STAB1	1.76e-21	60	77	14	IPR013111
Domain	EGF_2	SCARF1 ATRN ITGBL1 NELL2 RELN MEGF6 ADAM33 ADAM32 ITGB2 ITGB5 ITGB6 MEGF11 SVEP1 STAB1	1.76e-21	60	77	14	PF07974
Domain	EGF-like_CS	SCARF1 ATRN NELL2 RELN FBLN2 MEGF6 LAMA2 LAMA4 ADAM30 ADAM33 C8B ADAM32 ITGB2 VWDE ITGB5 ITGB6 MEGF11 SVEP1 CRB1 STAB1	2.81e-20	261	77	20	IPR013032
Domain	EGF	SCARF1 ATRN ITGBL1 NELL2 RELN FBLN2 FCGBP MEGF6 LAMA2 LAMA4 ADAM33 ADAM32 TECTA VWDE ITGB5 MEGF11 SVEP1 CRB1 STAB1	1.00e-19	235	77	19	SM00181
Domain	EGF_3	SCARF1 ATRN NELL2 RELN FBLN2 MEGF6 ADAM30 ADAM33 C8B ADAM32 SSPOP VWDE MEGF11 SVEP1 CRB1 OTOG STAB1	6.97e-17	235	77	17	PS50026
Domain	Growth_fac_rcpt_	SCARF1 ATRN ERBB3 NELL2 FBLN2 IGF1R IGFBP3 MEGF6 EGFR INSR KAZALD1 SVEP1 CRB1 STAB1	2.38e-15	156	77	14	IPR009030
Domain	VWD	FCGBP VWF MUC5B TECTA SSPOP VWDE OTOG	1.70e-13	16	77	7	SM00216
Domain	VWF_type-D	FCGBP VWF MUC5B TECTA SSPOP VWDE OTOG	1.70e-13	16	77	7	IPR001846
Domain	VWFD	FCGBP VWF MUC5B TECTA SSPOP VWDE OTOG	1.70e-13	16	77	7	PS51233
Domain	VWD	FCGBP VWF MUC5B TECTA SSPOP VWDE OTOG	1.70e-13	16	77	7	PF00094
Domain	VWC_out	NELL2 FCGBP VWF MUC5B TECTA SSPOP OTOG	7.41e-13	19	77	7	SM00215
Domain	TIL	FCGBP VWF MUC5B TECTA SSPOP OTOG	3.65e-12	12	77	6	PF01826
Domain	C8	FCGBP VWF MUC5B TECTA SSPOP OTOG	3.65e-12	12	77	6	PF08742
Domain	Unchr_dom_Cys-rich	FCGBP VWF MUC5B TECTA SSPOP OTOG	6.75e-12	13	77	6	IPR014853
Domain	C8	FCGBP VWF MUC5B TECTA SSPOP OTOG	6.75e-12	13	77	6	SM00832
Domain	TIL_dom	FCGBP VWF MUC5B TECTA SSPOP OTOG	1.18e-11	14	77	6	IPR002919
Domain	Laminin_EGF	SCARF1 ATRN MEGF6 LAMA2 LAMA4 MEGF11 STAB1	9.39e-11	35	77	7	PF00053
Domain	Laminin_EGF	SCARF1 ATRN MEGF6 LAMA2 LAMA4 MEGF11 STAB1	1.74e-10	38	77	7	IPR002049
Domain	VWF_dom	NELL2 FCGBP VWF MUC5B TECTA SSPOP OTOG	3.68e-10	42	77	7	IPR001007
Domain	EGF_Lam	ATRN MEGF6 LAMA2 LAMA4 MEGF11 STAB1	5.94e-09	35	77	6	SM00180
Domain	Furin-like	ERBB3 IGF1R EGFR INSR	9.26e-09	7	77	4	PF00757
Domain	Rcpt_L-dom	ERBB3 IGF1R EGFR INSR	9.26e-09	7	77	4	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB3 IGF1R EGFR INSR	9.26e-09	7	77	4	IPR006211
Domain	Recep_L_domain	ERBB3 IGF1R EGFR INSR	9.26e-09	7	77	4	PF01030
Domain	-	ERBB3 IGF1R EGFR INSR	9.26e-09	7	77	4	3.80.20.20
Domain	VWC	NELL2 FCGBP VWF MUC5B TECTA SSPOP	1.00e-08	38	77	6	SM00214
Domain	Integrin_bsu	ITGBL1 ITGB2 ITGB5 ITGB6	3.31e-08	9	77	4	IPR015812
Domain	INTEGRIN_BETA	ITGBL1 ITGB2 ITGB5 ITGB6	3.31e-08	9	77	4	PS00243
Domain	VWFC_2	NELL2 VWF MUC5B TECTA SSPOP	4.71e-07	38	77	5	PS50184
Domain	Furin_repeat	ERBB3 IGF1R EGFR INSR	7.82e-07	18	77	4	IPR006212
Domain	FU	ERBB3 IGF1R EGFR INSR	7.82e-07	18	77	4	SM00261
Domain	EGF	ATRN MEGF6 TECTA ITGB5 SVEP1 CRB1 STAB1	8.74e-07	126	77	7	PF00008
Domain	Integrin_bsu_cyt_dom	ITGB2 ITGB5 ITGB6	1.34e-06	6	77	3	IPR014836
Domain	Integrin_b_cyt	ITGB2 ITGB5 ITGB6	1.34e-06	6	77	3	SM01241
Domain	Integrin_b_cyt	ITGB2 ITGB5 ITGB6	1.34e-06	6	77	3	PF08725
Domain	Integrin_bsu_tail	ITGB2 ITGB5 ITGB6	2.33e-06	7	77	3	IPR012896
Domain	Integrin_B_tail	ITGB2 ITGB5 ITGB6	2.33e-06	7	77	3	SM01242
Domain	Integrin_B_tail	ITGB2 ITGB5 ITGB6	2.33e-06	7	77	3	PF07965
Domain	Cys_knot_C	VWF MUC5B SSPOP OTOG	3.16e-06	25	77	4	IPR006207
Domain	CTCK_2	VWF MUC5B SSPOP OTOG	3.16e-06	25	77	4	PS01225
Domain	Integrin_beta	ITGB2 ITGB5 ITGB6	3.72e-06	8	77	3	PF00362
Domain	INB	ITGB2 ITGB5 ITGB6	3.72e-06	8	77	3	SM00187
Domain	Integrin_bsu_VWA	ITGB2 ITGB5 ITGB6	3.72e-06	8	77	3	IPR002369
Domain	hEGF	MEGF6 MEGF11 SVEP1 CRB1	5.07e-06	28	77	4	PF12661
Domain	Integin_beta_N	ITGB2 ITGB5 ITGB6	5.56e-06	9	77	3	IPR033760
Domain	PSI_integrin	ITGB2 ITGB5 ITGB6	5.56e-06	9	77	3	PF17205
Domain	EGF_LAM_2	ATRN LAMA2 LAMA4 STAB1	6.75e-06	30	77	4	PS50027
Domain	EGF_LAM_1	ATRN LAMA2 LAMA4 STAB1	6.75e-06	30	77	4	PS01248
Domain	EGF_CA	NELL2 FBLN2 MEGF6 SVEP1 CRB1 STAB1	1.11e-05	122	77	6	SM00179
Domain	EGF-like_Ca-bd_dom	NELL2 FBLN2 MEGF6 SVEP1 CRB1 STAB1	1.22e-05	124	77	6	IPR001881
Domain	-	VWF ITGB2 ITGB5 ITGB6 SVEP1	1.35e-05	74	77	5	3.40.50.410
Domain	VWFC_1	NELL2 VWF MUC5B SSPOP	1.42e-05	36	77	4	PS01208
Domain	Laminin_G_2	NELL2 LAMA2 LAMA4 CRB1	2.18e-05	40	77	4	PF02210
Domain	VWFA	VWF ITGB2 ITGB5 ITGB6 SVEP1	2.22e-05	82	77	5	PS50234
Domain	VWA	VWF ITGB2 ITGB5 ITGB6 SVEP1	2.50e-05	84	77	5	SM00327
Domain	PSI	ATRN ITGB2 ITGB5 ITGB6	3.20e-05	44	77	4	IPR016201
Domain	LamG	NELL2 LAMA2 LAMA4 CRB1	3.20e-05	44	77	4	SM00282
Domain	Disintegrin_CS	ADAM30 ADAM33 ADAM32	3.63e-05	16	77	3	IPR018358
Domain	PSI	ATRN ITGB2 ITGB5 ITGB6	3.82e-05	46	77	4	SM00423
Domain	EMI	MEGF6 SSPOP MEGF11	4.39e-05	17	77	3	PS51041
Domain	-	NELL2 LAMA2 LAMA4 SVEP1 CRB1	4.53e-05	95	77	5	2.60.120.200
Domain	EGF_Ca-bd_CS	NELL2 FBLN2 MEGF6 SVEP1 CRB1	5.01e-05	97	77	5	IPR018097
Domain	TILa	FCGBP TECTA	5.02e-05	3	77	2	PF12714
Domain	Cysteine_rich_secretory	CRISP2 CRISP3	5.02e-05	3	77	2	IPR013871
Domain	Crisp	CRISP2 CRISP3	5.02e-05	3	77	2	PF08562
Domain	TILa_dom	FCGBP TECTA	5.02e-05	3	77	2	IPR025615
Domain	Tyr_kinase_insulin-like_rcpt	IGF1R INSR	5.02e-05	3	77	2	IPR016246
Domain	CTCK_1	VWF MUC5B SSPOP	5.26e-05	18	77	3	PS01185
Domain	ADAM_CR	ADAM30 ADAM33 ADAM32	5.26e-05	18	77	3	PF08516
Domain	EGF_CA	NELL2 FBLN2 MEGF6 SVEP1 CRB1	5.52e-05	99	77	5	PS01187
Domain	VWF_A	VWF ITGB2 ITGB5 ITGB6 SVEP1	5.52e-05	99	77	5	IPR002035
Domain	ASX_HYDROXYL	NELL2 FBLN2 MEGF6 SVEP1 CRB1	5.79e-05	100	77	5	PS00010
Domain	-	ADAM30 ADAM33 ADAM32	7.30e-05	20	77	3	4.10.70.10
Domain	EGF-type_Asp/Asn_hydroxyl_site	NELL2 FBLN2 MEGF6 SVEP1 CRB1	7.65e-05	106	77	5	IPR000152
Domain	Disintegrin	ADAM30 ADAM33 ADAM32	8.49e-05	21	77	3	PF00200
Domain	DISIN	ADAM30 ADAM33 ADAM32	8.49e-05	21	77	3	SM00050
Domain	Laminin_G	NELL2 LAMA2 LAMA4 CRB1	9.57e-05	58	77	4	IPR001791
Domain	CT	VWF MUC5B OTOG	9.81e-05	22	77	3	SM00041
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB3 EGFR	1.00e-04	4	77	2	IPR016245
Domain	-	ITGB5 ITGB6	1.00e-04	4	77	2	1.20.5.630
Domain	Integrin_dom	ITGB2 ITGB5 ITGB6	1.45e-04	25	77	3	IPR032695
Domain	Laminin_aI	LAMA2 LAMA4	1.66e-04	5	77	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA4	1.66e-04	5	77	2	PF06008
Domain	Laminin_II	LAMA2 LAMA4	1.66e-04	5	77	2	PF06009
Domain	Laminin_domII	LAMA2 LAMA4	1.66e-04	5	77	2	IPR010307
Domain	SHKT	CRISP2 CRISP3	1.66e-04	5	77	2	PS51670
Domain	ShKT_dom	CRISP2 CRISP3	1.66e-04	5	77	2	IPR003582
Domain	ACR	ADAM30 ADAM33 ADAM32	1.84e-04	27	77	3	SM00608
Domain	ADAM_Cys-rich	ADAM30 ADAM33 ADAM32	1.84e-04	27	77	3	IPR006586
Domain	VWC	NELL2 VWF MUC5B	2.05e-04	28	77	3	PF00093
Domain	GF_recep_IV	ERBB3 EGFR	2.49e-04	6	77	2	PF14843
Domain	GF_recep_IV	ERBB3 EGFR	2.49e-04	6	77	2	IPR032778
Domain	Kazal_2	WFIKKN1 KAZALD1 SLCO6A1	4.36e-04	36	77	3	PF07648
Domain	EGF_CA	NELL2 FBLN2 MEGF6 SVEP1	4.39e-04	86	77	4	PF07645
Pathway	REACTOME_KERATINIZATION	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	1.95e-14	217	62	15	M27640
Pathway	REACTOME_KERATINIZATION	KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	9.10e-14	153	62	13	MM15343
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	RELN KRTAP9-4 KRTAP4-1 EGFR KRTAP9-6 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	3.04e-09	502	62	15	MM14537
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	RELN IGF1R VWF EGFR INSR LAMA2 LAMA4 PDGFC ITGB2 ITGB5 ITGB6	7.00e-08	302	62	11	M39719
Pathway	WP_FOCAL_ADHESION	RELN VWF EGFR LAMA2 LAMA4 PDGFC ITGB2 ITGB5 ITGB6	1.16e-07	187	62	9	MM15913
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	RELN IGF1R VWF EGFR INSR LAMA2 LAMA4 PDGFC ITGB2 ITGB5 ITGB6	1.52e-07	326	62	11	MM15917
Pathway	WP_FOCAL_ADHESION	RELN IGF1R VWF EGFR LAMA2 LAMA4 PDGFC ITGB5 ITGB6	1.97e-07	199	62	9	M39402
Pathway	KEGG_FOCAL_ADHESION	RELN IGF1R VWF EGFR LAMA2 LAMA4 PDGFC ITGB5 ITGB6	1.97e-07	199	62	9	M7253
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	RELN VWF LAMA2 LAMA4 ITGB5 ITGB6	1.76e-06	84	62	6	M7098
Pathway	WP_PI3KAKT_SIGNALING	RELN IGF1R VWF EGFR INSR LAMA2 LAMA4 PDGFC ITGB5 ITGB6	2.01e-06	339	62	10	M39736
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	ERBB3 IGF1R EGFR INSR	4.00e-06	25	62	4	M47934
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	KRTAP4-4 KRTAP4-7 NELL2 RELN KRTAP9-4 KRTAP4-1 EGFR KRTAP9-6 KRTAP4-2 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 LAMA2 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	7.12e-06	1432	62	19	M509
Pathway	WP_HIPPOMERLIN_SIGNALING_DYSREGULATION	IGF1R EGFR INSR ITGB2 ITGB5 ITGB6	1.47e-05	121	62	6	M39823
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY	ERBB3 IGF1R EGFR INSR PDGFC	3.12e-05	83	62	5	M47961
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY	ERBB3 IGF1R EGFR INSR PDGFC	4.36e-05	89	62	5	M47963
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	ERBB3 EGFR LAMA2 LAMA4	4.82e-05	46	62	4	M239
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY	ERBB3 IGF1R EGFR INSR PDGFC	5.12e-05	92	62	5	M47927
Pathway	BIOCARTA_HDAC_PATHWAY	IGF1R INSR CAMK1G	1.74e-04	25	62	3	M1547
Pathway	BIOCARTA_ERBB3_PATHWAY	ERBB3 EGFR	1.89e-04	5	62	2	M22018
Pathway	PID_INTEGRIN_CS_PATHWAY	ITGB2 ITGB5 ITGB6	1.96e-04	26	62	3	M47
Pathway	BIOCARTA_ERBB3_PATHWAY	ERBB3 EGFR	2.82e-04	6	62	2	MM1543
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	FBLN2 VWF LAMA2 LAMA4 ITGB2 ITGB5 ITGB6	3.33e-04	300	62	7	M610
Pathway	BIOCARTA_AGR_PATHWAY	EGFR LAMA2 LAMA4	3.34e-04	31	62	3	MM1343
Pathway	REACTOME_ECM_PROTEOGLYCANS	LAMA2 LAMA4 ITGB5 ITGB6	3.43e-04	76	62	4	M27219
Pathway	BIOCARTA_AGR_PATHWAY	EGFR LAMA2 LAMA4	4.02e-04	33	62	3	M6220
Pathway	WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE	ERBB3 IGF1R EGFR PDGFC	5.03e-04	84	62	4	M39839
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	VWF ITGB2 ITGB5 ITGB6	5.26e-04	85	62	4	M16441
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBLN2 ITGB5 ITGB6	5.66e-04	37	62	3	M27134
Pathway	PID_UPA_UPAR_PATHWAY	EGFR ITGB2 ITGB5	8.23e-04	42	62	3	M174
Pathway	WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS	LAMA4 ITGB5 ITGB6	8.82e-04	43	62	3	M39565
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	FBLN2 VWF MEGF6 LAMA4 ITGB2 ITGB6	9.25e-04	258	62	6	MM14572
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBLN2 ITGB5 ITGB6	9.44e-04	44	62	3	M26969
Pathway	REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA	ADAM30 ZP3	1.02e-03	11	62	2	M27184
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB3 EGFR	1.02e-03	11	62	2	MM15478
Pathway	REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA	ADAM30 ZP3	1.02e-03	11	62	2	MM14897
Pathway	WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS	ITGB2 ITGB5 ITGB6	1.14e-03	47	62	3	M39829
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB3 EGFR	1.44e-03	13	62	2	M27729
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB3 EGFR	1.44e-03	13	62	2	MM15320
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY	EGFR CAMK1G	1.67e-03	14	62	2	M47386
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB3 EGFR	1.67e-03	14	62	2	MM14761
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB3 EGFR	1.67e-03	14	62	2	MM14531
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	ERBB3 EGFR PDGFC	1.81e-03	55	62	3	M47952
Pathway	PID_ERBB_NETWORK_PATHWAY	ERBB3 EGFR	1.93e-03	15	62	2	M201
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB3 EGFR	1.93e-03	15	62	2	M27608
Pathway	REACTOME_LAMININ_INTERACTIONS	MEGF6 LAMA4	1.93e-03	15	62	2	MM14922
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY	EGFR CAMK1G	1.93e-03	15	62	2	M47385
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB3 EGFR	2.20e-03	16	62	2	M570
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	LAMA2 LAMA4 ITGB5	2.21e-03	59	62	3	M27218
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	ERBB3 IGF1R MEGF6 EGFR INSR LAMA4 PDGFC	2.31e-03	418	62	7	MM15587
Pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	EGFR PDGFC ITGB2 ITGB5 ITGB6	2.42e-03	213	62	5	M18306
Pathway	PID_INTEGRIN5_PATHWAY	ITGB5 ITGB6	2.48e-03	17	62	2	M212
Pathway	BIOCARTA_TEL_PATHWAY	IGF1R EGFR	2.48e-03	17	62	2	MM1508
Pathway	BIOCARTA_TEL_PATHWAY	IGF1R EGFR	2.48e-03	17	62	2	M10401
Pathway	WP_PLEURAL_MESOTHELIOMA	IGF1R EGFR INSR LAMA2 LAMA4 PDGFC ITGB2	3.04e-03	439	62	7	M42563
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	MEGF6 LAMA4	3.10e-03	19	62	2	MM15512
Pathway	KEGG_MELANOMA	IGF1R EGFR PDGFC	3.74e-03	71	62	3	M15798
Pathway	KEGG_ADHERENS_JUNCTION	IGF1R EGFR INSR	4.05e-03	73	62	3	M638
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB3 EGFR	4.15e-03	22	62	2	M26929
Pathway	WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY	LAMA2 ITGB5 ITGB6	4.21e-03	74	62	3	M39462
Pathway	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	LAMA2 ITGB5 ITGB6	4.21e-03	74	62	3	M16376
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	VWF ITGB2 ITGB6	4.53e-03	76	62	3	MM14867
Pathway	BIOCARTA_HER2_PATHWAY	ERBB3 EGFR	4.54e-03	23	62	2	MM1480
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY	IGF1R EGFR	4.54e-03	23	62	2	M48234
Pathway	BIOCARTA_HER2_PATHWAY	ERBB3 EGFR	4.54e-03	23	62	2	M18719
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY	ITGB5 ITGB6	4.54e-03	23	62	2	M47537
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY	ITGB5 ITGB6	4.54e-03	23	62	2	M47720
Pubmed	Characterization of a cluster of human high/ultrahigh sulfur keratin-associated protein genes embedded in the type I keratin gene domain on chromosome 17q12-21.	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP4-6 KRTAP9-9 KRTAP4-9	7.30e-31	37	81	15	11279113
Pubmed	Molecular evolution of the keratin associated protein gene family in mammals, role in the evolution of mammalian hair.	KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9	8.60e-20	69	81	12	18721477
Pubmed	Size polymorphisms in the human ultrahigh sulfur hair keratin-associated protein 4, KAP4, gene family.	KRTAP4-4 KRTAP4-7 KRTAP4-1 KRTAP4-3 KRTAP4-8 KRTAP4-6	3.68e-15	8	81	6	15955084
Pubmed	An ultra-high sulfur keratin gene is expressed specifically during hair growth.	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9	3.68e-15	8	81	6	2465353
Pubmed	Pax9 is required for filiform papilla development and suppresses skin-specific differentiation of the mammalian tongue epithelium.	KRTAP9-4 KRTAP9-6 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9	2.93e-11	26	81	6	15454262
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	ERBB3 IGF1R EGFR INSR ITGB2 ITGB5 ITGB6	4.11e-09	101	81	7	23382219
Pubmed	Beta1 integrins control the formation of cell chains in the adult rostral migratory stream.	LAMA2 LAMA4 ITGB5	4.86e-08	4	81	3	17344408
Pubmed	Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer.	ERBB3 IGF1R INSR	4.86e-08	4	81	3	24973425
Pubmed	Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.	IGF1R EGFR INSR	4.86e-08	4	81	3	9506989
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	RELN FBLN2 VWF MEGF6 LAMA2 LAMA4 SSPOP	1.84e-07	175	81	7	28071719
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	ZNF821 LRP12 LAMA2 SSPOP CRB1	6.98e-07	71	81	5	33541421
Pubmed	Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.	IGF1R EGFR INSR	1.01e-06	9	81	3	11094073
Pubmed	Inceptor counteracts insulin signalling in β-cells to control glycaemia.	ERBB3 IGF1R IGFBP3 INSR	1.20e-06	34	81	4	33505018
Pubmed	Hair greying is associated with active hair growth.	KRTAP4-3 KRTAP4-8 KRTAP4-9	1.44e-06	10	81	3	21916889
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	ITGBL1 FBLN2 VWF IGFBP3 LAMA2 LAMA4 SVEP1	1.91e-06	248	81	7	24006456
Pubmed	Otogelin, otogelin-like, and stereocilin form links connecting outer hair cell stereocilia to each other and the tectorial membrane.	OTOGL TECTA OTOG	1.98e-06	11	81	3	31776257
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	ERBB3 IGF1R EGFR INSR	2.34e-06	40	81	4	30898150
Pubmed	Integrins.	ITGB2 ITGB5 ITGB6	2.64e-06	12	81	3	19693543
Pubmed	The FOXG1/FOXO/SMAD network balances proliferation and differentiation of cortical progenitors and activates Kcnh3 expression in mature neurons.	NELL2 RELN IGF1R IGFBP3	3.45e-06	44	81	4	27224923
Pubmed	Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.	IGF1R INSR	5.36e-06	2	81	2	22438913
Pubmed	Differential androgen regulation of the murine genes for cysteine-rich secretory proteins (CRISP).	CRISP2 CRISP3	5.36e-06	2	81	2	9428696
Pubmed	Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.	IGF1R EGFR	5.36e-06	2	81	2	26554308
Pubmed	Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer.	ERBB3 IGF1R	5.36e-06	2	81	2	31728045
Pubmed	EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor.	ERBB3 EGFR	5.36e-06	2	81	2	34884742
Pubmed	Insulin and IGF-1 have both overlapping and distinct effects on CD4+ T cell mitochondria, metabolism, and function.	IGF1R INSR	5.36e-06	2	81	2	38383709
Pubmed	Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.	IGF1R INSR	5.36e-06	2	81	2	24809298
Pubmed	A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis.	IGF1R INSR	5.36e-06	2	81	2	21139139
Pubmed	The insulin and IGF1 receptor kinase domains are functional dimers in the activated state.	IGF1R INSR	5.36e-06	2	81	2	25758790
Pubmed	Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.	IGF1R EGFR	5.36e-06	2	81	2	17320820
Pubmed	Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance.	IGF1R IGFBP3	5.36e-06	2	81	2	24811788
Pubmed	Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.	IGF1R INSR	5.36e-06	2	81	2	27384680
Pubmed	Spermidine overrides INSR (insulin receptor)-IGF1R (insulin-like growth factor 1 receptor)-mediated inhibition of autophagy in the aging heart.	IGF1R INSR	5.36e-06	2	81	2	35786404
Pubmed	Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma.	IGF1R EGFR	5.36e-06	2	81	2	27105537
Pubmed	Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven Gliomas.	IGF1R INSR	5.36e-06	2	81	2	28138037
Pubmed	The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation.	IGF1R EGFR	5.36e-06	2	81	2	27213344
Pubmed	Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.	IGF1R INSR	5.36e-06	2	81	2	30070361
Pubmed	ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.	ERBB3 EGFR	5.36e-06	2	81	2	20647770
Pubmed	Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes.	IGF1R INSR	5.36e-06	2	81	2	31562314
Pubmed	Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.	IGF1R INSR	5.36e-06	2	81	2	14722023
Pubmed	Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer.	ERBB3 EGFR	5.36e-06	2	81	2	37156315
Pubmed	Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.	IGF1R INSR	5.36e-06	2	81	2	17416680
Pubmed	Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling.	IGF1R INSR	5.36e-06	2	81	2	22692545
Pubmed	Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors.	ERBB3 EGFR	5.36e-06	2	81	2	26034219
Pubmed	High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.	IGF1R INSR	5.36e-06	2	81	2	21177763
Pubmed	IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations.	IGF1R EGFR	5.36e-06	2	81	2	23994953
Pubmed	EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis.	ERBB3 EGFR	5.36e-06	2	81	2	27756321
Pubmed	Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes.	IGF1R INSR	5.36e-06	2	81	2	18693051
Pubmed	Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells.	IGF1R EGFR	5.36e-06	2	81	2	25341922
Pubmed	IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.	IGF1R IGFBP3	5.36e-06	2	81	2	23962053
Pubmed	A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer.	IGF1R EGFR	5.36e-06	2	81	2	28498434
Pubmed	Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function.	IGF1R INSR	5.36e-06	2	81	2	19817984
Pubmed	Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy.	IGF1R INSR	5.36e-06	2	81	2	19744489
Pubmed	Adipocyte Dynamics and Reversible Metabolic Syndrome in Mice with an Inducible Adipocyte-Specific Deletion of the Insulin Receptor.	IGF1R INSR	5.36e-06	2	81	2	28065828
Pubmed	Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior.	IGF1R INSR	5.36e-06	2	81	2	30765523
Pubmed	Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.	IGF1R INSR	5.36e-06	2	81	2	24302626
Pubmed	Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells.	IGF1R INSR	5.36e-06	2	81	2	22879999
Pubmed	Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.	IGF1R EGFR	5.36e-06	2	81	2	25617986
Pubmed	Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.	IGF1R EGFR	5.36e-06	2	81	2	17525128
Pubmed	Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling.	IGF1R INSR	5.36e-06	2	81	2	36548088
Pubmed	Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.	IGF1R EGFR	5.36e-06	2	81	2	22700994
Pubmed	Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function.	IGF1R INSR	5.36e-06	2	81	2	17189427
Pubmed	Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.	ERBB3 EGFR	5.36e-06	2	81	2	26844548
Pubmed	The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor.	IGF1R EGFR	5.36e-06	2	81	2	24458568
Pubmed	Both epidermal growth factor and insulin-like growth factor receptors are dispensable for structural intestinal adaptation.	IGF1R EGFR	5.36e-06	2	81	2	25818318
Pubmed	[Effects of insulin on expression of insulin receptor and insulin-like growth factor-1 receptor and proliferation in Reh cells].	IGF1R INSR	5.36e-06	2	81	2	22541124
Pubmed	A functional assessment of insulin/insulin-like growth factor-I hybrid receptors.	IGF1R INSR	5.36e-06	2	81	2	7895674
Pubmed	Laminins alpha2 and alpha4 in pancreatic acinar basement membranes are required for basal receptor localization.	LAMA2 LAMA4	5.36e-06	2	81	2	14729866
Pubmed	Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice.	IGF1R INSR	5.36e-06	2	81	2	19851056
Pubmed	Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers.	ERBB3 EGFR	5.36e-06	2	81	2	32080212
Pubmed	Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.	IGF1R EGFR	5.36e-06	2	81	2	23314677
Pubmed	Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups.	IGF1R INSR	5.36e-06	2	81	2	28030849
Pubmed	Mutual regulation between IGF-1R and IGFBP-3 in human corneal epithelial cells.	IGF1R IGFBP3	5.36e-06	2	81	2	30078228
Pubmed	Allurin, a 21-kDa sperm chemoattractant from Xenopus egg jelly, is related to mammalian sperm-binding proteins.	CRISP2 CRISP3	5.36e-06	2	81	2	11562501
Pubmed	Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.	IGF1R INSR	5.36e-06	2	81	2	19406949
Pubmed	Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.	IGF1R INSR	5.36e-06	2	81	2	27905925
Pubmed	Placental glycogen stores are increased in mice with H19 null mutations but not in those with insulin or IGF type 1 receptor mutations.	IGF1R INSR	5.36e-06	2	81	2	19524295
Pubmed	Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation.	IGF1R INSR	5.36e-06	2	81	2	18650937
Pubmed	A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding.	IGF1R INSR	5.36e-06	2	81	2	30213860
Pubmed	Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines.	IGF1R INSR	5.36e-06	2	81	2	22161861
Pubmed	Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action.	IGF1R IGFBP3	5.36e-06	2	81	2	9389554
Pubmed	Male Brown Fat-Specific Double Knockout of IGFIR/IR: Atrophy, Mitochondrial Fission Failure, Impaired Thermogenesis, and Obesity.	IGF1R INSR	5.36e-06	2	81	2	29040448
Pubmed	EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.	ERBB3 EGFR	5.36e-06	2	81	2	31092882
Pubmed	A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.	IGF1R INSR	5.36e-06	2	81	2	19139090
Pubmed	Apolipoprotein C3 and circulating mediators of preadipocyte proliferation in states of lipodystrophy.	IGF1R INSR	5.36e-06	2	81	2	35964946
Pubmed	Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization.	IGF1R INSR	5.36e-06	2	81	2	12813019
Pubmed	Epigenetic DNA methylation in the promoters of the Igf1 receptor and insulin receptor genes in db/db mice.	IGF1R INSR	5.36e-06	2	81	2	21474992
Pubmed	Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases.	ERBB3 EGFR	5.36e-06	2	81	2	27872189
Pubmed	Endothelial Cell Mediated Promotion of Ciliated Cell Differentiation of Human Airway Basal Cells via Insulin and Insulin-Like Growth Factor 1 Receptor Mediated Signaling.	IGF1R INSR	5.36e-06	2	81	2	28050756
Pubmed	Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes.	IGF1R INSR	5.36e-06	2	81	2	16642022
Pubmed	Cloning and characterization of the rat Crisp-1 gene.	CRISP2 CRISP3	5.36e-06	2	81	2	10580147
Pubmed	IGF1R Expression in Ovarian Granulosa Cells Is Essential for Steroidogenesis, Follicle Survival, and Fertility in Female Mice.	IGF1R INSR	5.36e-06	2	81	2	28407051
Pubmed	BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis.	IGF1R INSR	5.36e-06	2	81	2	26438154
Pubmed	Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms.	IGF1R INSR	5.36e-06	2	81	2	23671263
Pubmed	Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.	IGF1R EGFR	5.36e-06	2	81	2	18829558
Pubmed	Suppression of Cardiac Autophagy by Hyperinsulinemia in Insulin Receptor-Deficient Hearts Is Mediated by Insulin-Like Growth Factor Receptor Signaling.	IGF1R INSR	5.36e-06	2	81	2	31088290
Pubmed	Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.	IGF1R EGFR	5.36e-06	2	81	2	19033715
Pubmed	Development of a Quantitative PCR Assay for Detection of Human Insulin-Like Growth Factor Receptor and Insulin Receptor Isoforms.	IGF1R INSR	5.36e-06	2	81	2	26862994
Pubmed	An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC.	ERBB3 EGFR	5.36e-06	2	81	2	30302022
Pubmed	Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level.	IGF1R INSR	5.36e-06	2	81	2	18708119
Pubmed	Quantitative proteome analysis of alveolar type-II cells reveals a connection of integrin receptor subunits beta 2/6 and WNT signaling.	ITGB2 ITGB6	5.36e-06	2	81	2	24175614
Interaction	SMCP interactions	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	9.53e-12	79	72	9	int:SMCP
Interaction	HOXA1 interactions	KRTAP4-4 KRTAP4-7 NELL2 FBLN2 VWF KRTAP9-4 MEGF6 KRTAP4-1 KRTAP4-2 KRTAP4-12 SUV39H1 KRTAP9-2 KRTAP9-8 KRTAP9-3	2.64e-11	356	72	14	int:HOXA1
Interaction	LCE3E interactions	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.92e-11	60	72	8	int:LCE3E
Interaction	CRCT1 interactions	KRTAP4-4 KRTAP4-1 EGFR KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	8.66e-11	66	72	8	int:CRCT1
Interaction	LCE3C interactions	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	9.80e-11	67	72	8	int:LCE3C
Interaction	LCE1D interactions	SCARF1 KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.41e-10	70	72	8	int:LCE1D
Interaction	OTX1 interactions	KRTAP4-4 KRTAP4-7 FBLN2 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.93e-10	155	72	10	int:OTX1
Interaction	LCE3D interactions	KRTAP4-4 FBLN2 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.99e-10	73	72	8	int:LCE3D
Interaction	NUFIP2 interactions	KRTAP4-4 NELL2 FBLN2 VWF KRTAP9-4 MEGF6 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 MEGF11 STAB1	2.13e-10	417	72	14	int:NUFIP2
Interaction	CATSPER1 interactions	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	6.68e-10	126	72	9	int:CATSPER1
Interaction	LCE1B interactions	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	6.87e-10	85	72	8	int:LCE1B
Interaction	KRTAP10-8 interactions	SCARF1 KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-2 KRTAP4-12 SUV39H1 KRTAP9-2 KRTAP9-8 KRTAP9-3 CAMK1G ITGB2 ITGB5	1.55e-09	401	72	13	int:KRTAP10-8
Interaction	KRTAP5-6 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.55e-09	94	72	8	int:KRTAP5-6
Interaction	PHLDA1 interactions	ERBB3 EGFR KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.63e-09	66	72	7	int:PHLDA1
Interaction	LCE2D interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	8.20e-09	74	72	7	int:LCE2D
Interaction	LCE3A interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	9.90e-09	76	72	7	int:LCE3A
Interaction	LCE3B interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.41e-08	46	72	6	int:LCE3B
Interaction	LCE4A interactions	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.42e-08	80	72	7	int:LCE4A
Interaction	LCE1A interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	2.01e-08	84	72	7	int:LCE1A
Interaction	LCE2C interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	2.78e-08	88	72	7	int:LCE2C
Interaction	LCE5A interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.25e-08	90	72	7	int:LCE5A
Interaction	LCE1F interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.79e-08	92	72	7	int:LCE1F
Interaction	KRTAP9-2 interactions	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	5.93e-08	149	72	8	int:KRTAP9-2
Interaction	KRTAP10-1 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 CAMK1G	7.29e-08	153	72	8	int:KRTAP10-1
Interaction	KRTAP5-4 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	9.73e-08	63	72	6	int:KRTAP5-4
Interaction	KRTAP10-11 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.07e-07	64	72	6	int:KRTAP10-11
Interaction	CREB5 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.25e-07	164	72	8	int:CREB5
Interaction	KRTAP5-3 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.29e-07	66	72	6	int:KRTAP5-3
Interaction	LCE1E interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.55e-07	68	72	6	int:LCE1E
Interaction	NR4A3 interactions	KRTAP4-4 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3 MGA	1.69e-07	69	72	6	int:NR4A3
Interaction	LCE2A interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.69e-07	69	72	6	int:LCE2A
Interaction	KRTAP10-9 interactions	KRTAP4-4 KRTAP9-4 EGFR KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB5	1.90e-07	241	72	9	int:KRTAP10-9
Interaction	KRTAP5-7 interactions	SCARF1 KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 ITGB5	2.00e-07	71	72	6	int:KRTAP5-7
Interaction	LCE1C interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.26e-07	77	72	6	int:LCE1C
Interaction	KRTAP4-4 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	4.42e-07	81	72	6	int:KRTAP4-4
Interaction	LCE2B interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	4.42e-07	81	72	6	int:LCE2B
Interaction	KRTAP4-2 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	4.56e-07	132	72	7	int:KRTAP4-2
Interaction	POU4F2 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	5.11e-07	83	72	6	int:POU4F2
Interaction	KRTAP9-3 interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	6.79e-07	140	72	7	int:KRTAP9-3
Interaction	SLC13A5 interactions	EGFR KRTAP9-2 KRTAP9-8 KRTAP9-3	8.56e-07	21	72	4	int:SLC13A5
Interaction	NOTCH2NLA interactions	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB2 ITGB5	9.80e-07	381	72	10	int:NOTCH2NLA
Interaction	KRTAP10-7 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 ZNF425 SUV39H1 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB5	9.80e-07	293	72	9	int:KRTAP10-7
Interaction	KRTAP26-1 interactions	KRTAP4-4 KRTAP4-7 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8	1.07e-06	94	72	6	int:KRTAP26-1
Interaction	CHRD interactions	CRISP2 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-3 TWSG1	1.07e-06	94	72	6	int:CHRD
Interaction	KRTAP1-1 interactions	SCARF1 KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB5	1.13e-06	219	72	8	int:KRTAP1-1
Interaction	SHFL interactions	KRTAP4-4 EGFR KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-3	1.29e-06	97	72	6	int:SHFL
Interaction	DUSP18 interactions	ERBB3 IGF1R EGFR INSR	1.51e-06	24	72	4	int:DUSP18
Interaction	KRTAP9-8 interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.54e-06	100	72	6	int:KRTAP9-8
Interaction	KRTAP10-5 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.67e-06	160	72	7	int:KRTAP10-5
Interaction	NBPF19 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB2 ITGB5	1.79e-06	233	72	8	int:NBPF19
Interaction	GNE interactions	KRTAP4-4 KRTAP4-1 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.94e-06	104	72	6	int:GNE
Interaction	KRTAP5-2 interactions	KRTAP4-4 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	2.79e-06	62	72	5	int:KRTAP5-2
Interaction	KRTAP5-11 interactions	KRTAP4-4 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.81e-06	66	72	5	int:KRTAP5-11
Interaction	KRTAP1-3 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB5	4.21e-06	184	72	7	int:KRTAP1-3
Interaction	ATN1 interactions	NELL2 FBLN2 MEGF6 KRTAP4-12 KRTAP9-3 SSPOP MEGF11	4.69e-06	187	72	7	int:ATN1
Interaction	SH2B1 interactions	ERBB3 IGF1R EGFR INSR	4.99e-06	32	72	4	int:SH2B1
Interaction	GLRX3 interactions	KRTAP4-4 KRTAP4-7 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	5.39e-06	191	72	7	int:GLRX3
Interaction	ITGB4 interactions	EGFR KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3 ADAM30	5.64e-06	125	72	6	int:ITGB4
Interaction	KRTAP4-5 interactions	KRTAP4-4 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	7.67e-06	76	72	5	int:KRTAP4-5
Interaction	KRTAP5-9 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	8.03e-06	203	72	7	int:KRTAP5-9
Interaction	KRTAP3-2 interactions	KRTAP4-4 KRTAP4-12 KRTAP9-2 KRTAP9-3 ITGB5	9.28e-06	79	72	5	int:KRTAP3-2
Interaction	ADAMTSL4 interactions	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-3 ITGB2	1.24e-05	217	72	7	int:ADAMTSL4
Interaction	FBXO2 interactions	ATRN NELL2 IGF1R EGFR SPRING1 INSR LAMA4 ADAM33 ITGB5	1.53e-05	411	72	9	int:FBXO2
Interaction	KRTAP4-11 interactions	KRTAP4-4 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.95e-05	92	72	5	int:KRTAP4-11
Interaction	LTBP1 interactions	NELL2 FBLN2 IGFBP3 LAMA2 ITGB5	1.95e-05	92	72	5	int:LTBP1
Interaction	KRTAP2-3 interactions	KRTAP4-4 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	2.28e-05	95	72	5	int:KRTAP2-3
Interaction	VASN interactions	KRTAP4-4 KRTAP4-1 KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	2.31e-05	160	72	6	int:VASN
Interaction	KRTAP4-7 interactions	KRTAP4-7 EGFR KRTAP9-2	2.37e-05	16	72	3	int:KRTAP4-7
Interaction	PATE1 interactions	ATRN EGFR INSR ITGB5	2.81e-05	49	72	4	int:PATE1
Interaction	KRTAP2-4 interactions	KRTAP4-4 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	3.07e-05	101	72	5	int:KRTAP2-4
Interaction	MPZL2 interactions	IGF1R EGFR INSR	3.43e-05	18	72	3	int:MPZL2
Interaction	DAB1 interactions	ERBB3 RELN EGFR ITGB2 ITGB5	4.05e-05	107	72	5	int:DAB1
Interaction	FBXO34 interactions	KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	4.45e-05	55	72	4	int:FBXO34
Interaction	VAV3 interactions	ERBB3 IGF1R EGFR INSR	4.45e-05	55	72	4	int:VAV3
Interaction	ERO1B interactions	TCTN3 IGF1R EGFR INSR	4.45e-05	55	72	4	int:ERO1B
Interaction	ZNF627 interactions	NELL2 FBLN2 KAZALD1	4.77e-05	20	72	3	int:ZNF627
Interaction	ADAM12 interactions	IGFBP3 KRTAP4-12 KRTAP9-2 KRTAP9-8	5.49e-05	58	72	4	int:ADAM12
Interaction	DOK5 interactions	IGF1R EGFR INSR	5.55e-05	21	72	3	int:DOK5
Interaction	DOK1 interactions	EGFR INSR ITGB2 ITGB5	5.87e-05	59	72	4	int:DOK1
Interaction	HLA-A interactions	TCTN3 ERBB3 IGF1R EGFR INSR ADAM30 ADAM33	7.70e-05	289	72	7	int:HLA-A
Interaction	CYSRT1 interactions	SCARF1 KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3 ITGB2 ITGB5	8.32e-05	511	72	9	int:CYSRT1
Interaction	SPATA3 interactions	KRTAP4-2 KRTAP4-12 KRTAP9-2	8.39e-05	24	72	3	int:SPATA3
Interaction	ZDHHC15 interactions	ZNF821 LRP12 LAMA2 SSPOP CRB1	8.50e-05	125	72	5	int:ZDHHC15
Interaction	NPDC1 interactions	KRTAP4-4 KRTAP4-1 KRTAP4-12 KRTAP9-3	8.60e-05	65	72	4	int:NPDC1
Interaction	DOCK2 interactions	KRTAP9-4 KRTAP4-2 KRTAP9-2 KRTAP9-3	9.13e-05	66	72	4	int:DOCK2
Interaction	NR1D2 interactions	KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	9.68e-05	67	72	4	int:NR1D2
Interaction	ZNF696 interactions	FBLN2 KRTAP4-12 KRTAP9-2 KAZALD1	1.03e-04	68	72	4	int:ZNF696
Interaction	PPM1F interactions	ERBB3 IGF1R EGFR INSR	1.21e-04	71	72	4	int:PPM1F
Interaction	VGLL3 interactions	KRTAP4-2 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.28e-04	72	72	4	int:VGLL3
Interaction	AQP1 interactions	KRTAP4-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8	1.36e-04	138	72	5	int:AQP1
Interaction	MAPKBP1 interactions	KRTAP9-4 KRTAP4-12 KRTAP9-2 KRTAP9-3	1.43e-04	74	72	4	int:MAPKBP1
Interaction	IGFL3 interactions	ATRN LRP12 INSR VWDE	1.50e-04	75	72	4	int:IGFL3
Interaction	PTPN12 interactions	ERBB3 IGF1R EGFR INSR MGA	1.71e-04	145	72	5	int:PTPN12
Interaction	PRKAG1 interactions	EGFR KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8	1.82e-04	147	72	5	int:PRKAG1
Interaction	KRTAP4-1 interactions	KRTAP4-1 KRTAP9-8 KRTAP9-3	1.83e-04	31	72	3	int:KRTAP4-1
Interaction	GRB14 interactions	IGF1R EGFR INSR	1.83e-04	31	72	3	int:GRB14
Interaction	QSOX2 interactions	IGF1R EGFR SPRING1 INSR	1.84e-04	79	72	4	int:QSOX2
Interaction	PRKAB2 interactions	KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP9-2 KRTAP9-8 KRTAP9-3	1.89e-04	234	72	6	int:PRKAB2
Interaction	TTC13 interactions	IGF1R EGFR INSR ADAM30	1.93e-04	80	72	4	int:TTC13
Interaction	TNS2 interactions	KRTAP4-4 ERBB3 EGFR SUV39H1 TWSG1 ITGB5	1.94e-04	235	72	6	int:TNS2
Cytoband	17q12-q21	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP4-6	3.18e-23	32	81	11	17q12-q21
Cytoband	Ensembl 112 genes in cytogenetic band chr17q21	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	2.28e-16	473	81	16	chr17q21
Cytoband	17q21.2	KRTAP4-7 KRTAP4-8 KRTAP29-1 KRTAP9-9 KRTAP4-9	1.67e-07	70	81	5	17q21.2
Cytoband	20p13	ATRN OXT ADAM33	8.01e-04	102	81	3	20p13
Cytoband	Ensembl 112 genes in cytogenetic band chr20p13	ATRN OXT ADAM33	1.37e-03	123	81	3	chr20p13
Cytoband	6p12.3	CRISP2 CRISP3	1.86e-03	36	81	2	6p12.3
GeneFamily	Keratin associated proteins	KRTAP4-4 KRTAP4-7 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	4.57e-23	109	57	16	619
GeneFamily	CD molecules\|Integrin beta subunits	ITGBL1 ITGB2 ITGB5 ITGB6	1.11e-08	9	57	4	1159
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB3 EGFR	5.84e-05	4	57	2	1096
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ADAM30 ADAM33 ADAM32	8.24e-05	27	57	3	47
GeneFamily	Laminin subunits	LAMA2 LAMA4	6.32e-04	12	57	2	626
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	SCARF1 STAB1	3.26e-03	27	57	2	1253
GeneFamily	Complement system\|Sushi domain containing	C8B ITGB2	5.74e-03	36	57	2	492
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	IGF1R INSR	7.05e-03	40	57	2	321
Coexpression	NABA_ECM_GLYCOPROTEINS	NELL2 RELN FBLN2 VWF IGFBP3 OTOGL LAMA2 LAMA4 TECTA ZP3 SSPOP VWDE SVEP1 EGFEM1P OTOG	2.18e-17	191	80	15	MM17059
Coexpression	NABA_MATRISOME	NELL2 RELN FBLN2 VWF IGFBP3 MEGF6 OTOGL WFIKKN1 LAMA2 LAMA4 ADAM30 ADAM33 MUC5B KAZALD1 ADAM32 TECTA PDGFC ZP3 SSPOP VWDE MEGF11 SVEP1 EGFEM1P OTOG	1.74e-15	1008	80	24	MM17056
Coexpression	NABA_CORE_MATRISOME	NELL2 RELN FBLN2 VWF IGFBP3 OTOGL LAMA2 LAMA4 TECTA ZP3 SSPOP VWDE SVEP1 EGFEM1P OTOG	3.86e-15	270	80	15	MM17057
Coexpression	NABA_ECM_GLYCOPROTEINS	NELL2 RELN FBLN2 VWF IGFBP3 LAMA2 LAMA4 TECTA ZP3 SSPOP VWDE SVEP1 OTOG	3.11e-14	196	80	13	M3008
Coexpression	NABA_MATRISOME	NELL2 RELN FBLN2 VWF IGFBP3 MEGF6 WFIKKN1 LAMA2 LAMA4 ADAM30 ADAM33 MUC5B KAZALD1 ADAM32 TECTA PDGFC ZP3 SSPOP VWDE MEGF11 SVEP1 OTOG	2.73e-13	1026	80	22	M5889
Coexpression	NABA_CORE_MATRISOME	NELL2 RELN FBLN2 VWF IGFBP3 LAMA2 LAMA4 TECTA ZP3 SSPOP VWDE SVEP1 OTOG	2.37e-12	275	80	13	M5884
Coexpression	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-3 KRTAP9-2 KRTAP9-8 KRTAP9-3	7.14e-09	132	80	8	M3434
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	FBLN2 KRTAP9-4 KRTAP4-1 EGFR KRTAP9-6 KRTAP4-3 KRTAP9-2 KRTAP9-8 KRTAP9-3 LAMA2 KRTAP9-9 MGA SP110	8.17e-08	650	80	13	MM1042
Coexpression	HOLLERN_SQUAMOUS_BREAST_TUMOR	KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-3 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9	2.11e-07	204	80	8	MM966
Coexpression	MARTINEZ_RB1_TARGETS_DN	KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-3 KRTAP9-2 KRTAP9-8 KRTAP9-3 LAMA2 KRTAP9-9 PDGFC SP110	3.31e-06	630	80	11	MM1038
Coexpression	MARTINEZ_TP53_TARGETS_DN	KRTAP9-4 KRTAP4-1 EGFR KRTAP9-6 KRTAP4-3 KRTAP9-2 KRTAP9-8 KRTAP9-3 KRTAP9-9 MGA SP110	5.07e-06	659	80	11	MM1040
Coexpression	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	IGFBP3 LAMA4 ITGB2 ITGB5	2.27e-05	54	80	4	M4737
Coexpression	TRAVAGLINI_LUNG_MUCOUS_CELL	FCGBP IGFBP3 INSR CRISP3 MUC5B	4.11e-05	125	80	5	M41656
CoexpressionAtlas	kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_500	MEGF6 KRTAP4-2 KRTAP4-12 INSR KRTAP4-6 KRTAP4-9	3.58e-05	193	68	6	gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_500
CoexpressionAtlas	JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1	SCARF1 RELN VWF LAMA4 MT1HL1 STAB1	7.22e-05	219	68	6	JC_hmvEC_500_K1
CoexpressionAtlas	Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4	ITGBL1 FBLN2 IGFBP3 EGFR LAMA2 LAMA4 ITGB5 SVEP1	7.57e-05	437	68	8	GSM777046_500
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6\|TCGA-Skin / Sample_Type by Project: Shred V9	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP9-6 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP4-8 KRTAP9-8 KRTAP9-3 KRTAP29-1 KRTAP4-6 KRTAP9-9 KRTAP4-9	9.52e-21	146	80	14	522c32103c24fc26836bb5b642083904682d9292
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10\|TCGA-Bladder / Sample_Type by Project: Shred V9	KRTAP4-4 KRTAP9-4 KRTAP4-2 KRTAP4-12 KRTAP4-3 KRTAP9-8 KRTAP9-3 KRTAP4-6 KRTAP9-9	1.93e-12	129	80	9	6a201c6344a015e5cf2f79ccf397fd7ad66b6768
ToppCell	droplet-Tongue-Unstain-18m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRTAP4-4 KRTAP4-7 KRTAP4-1 KRTAP4-2 KRTAP4-8 KRTAP9-3 TM4SF4 KRTAP4-6 KRTAP4-9	2.54e-12	133	80	9	f7d0763b5eec2db33044d6850fd57462494038c1
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-7\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	KRTAP4-4 KRTAP9-4 KRTAP4-1 KRTAP4-2 KRTAP4-12 KRTAP9-8 KRTAP9-9 C8B	1.83e-11	106	80	8	117b53d525be929652fb998e250d7946170fbaf0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 FBLN2 IGFBP3 MEGF6 LAMA2 LAMA4 ADAM33 SVEP1	1.79e-09	188	80	8	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN2 IGFBP3 EGFR LAMA2 LAMA4 ADAM33 SVEP1	4.54e-08	186	80	7	7582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 IGFBP3 MEGF6 LAMA2 LAMA4 ADAM33 SVEP1	5.25e-08	190	80	7	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 TWSG1 SVEP1	5.64e-08	192	80	7	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 ITGB5 SVEP1	5.64e-08	192	80	7	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	facs-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IGFBP3 EGFR LAMA2 LAMA4 TWSG1 ITGB5 SVEP1	5.64e-08	192	80	7	8df15085b35b86f39debd933284cb703c5dd63c2
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 TWSG1 SVEP1	5.64e-08	192	80	7	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 EGFR LAMA2 LAMA4 TWSG1 ITGB5 SVEP1	5.84e-08	193	80	7	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 ITGB5 SVEP1	6.27e-08	195	80	7	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 TWSG1 ITGB5	6.49e-08	196	80	7	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 TWSG1 ITGB5	6.49e-08	196	80	7	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN2 IGFBP3 EGFR LAMA2 LAMA4 ADAM33 SVEP1	6.72e-08	197	80	7	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	5'-Adult-Appendix-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN2 IGFBP3 EGFR LAMA2 LAMA4 ADAM33 SVEP1	6.72e-08	197	80	7	b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 LAMA2 ADAM33 CAMK1G KAZALD1 SVEP1	6.80e-07	172	80	6	1ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 ADAM33 TECTA SVEP1	6.80e-07	172	80	6	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 LAMA2 ADAM33 CAMK1G KAZALD1 SVEP1	6.80e-07	172	80	6	ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN EGFR ADAM33 VWDE SVEP1 EGFEM1P	8.58e-07	179	80	6	cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN EGFR ADAM33 VWDE SVEP1 EGFEM1P	8.58e-07	179	80	6	01302505816f272243659e20d751b61a198a2fc0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN EGFR ADAM33 VWDE SVEP1 EGFEM1P	8.87e-07	180	80	6	c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCell	droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISP2 RELN FBLN2 MEGF6 KAZALD1 STAB1	1.04e-06	185	80	6	6a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCell	droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRISP2 RELN FBLN2 MEGF6 KAZALD1 STAB1	1.04e-06	185	80	6	64791056cdbb739136dbef08f4b16e2b5427faad
ToppCell	21-Trachea-Epithelial-Goblet-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	ERBB3 FCGBP INSR CRISP3 MUC5B KAZALD1	1.07e-06	186	80	6	f8cddad28896f0edf10a8645fa49a011b22b120d
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ITGBL1 FBLN2 EGFR LAMA2 ADAM33 SVEP1	1.11e-06	187	80	6	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN EGFR ADAM33 VWDE SVEP1 EGFEM1P	1.14e-06	188	80	6	c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.14e-06	188	80	6	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	facs-Skin-nan-18m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 LAMA2 LAMA4 ADAM33 SP110 SVEP1	1.18e-06	189	80	6	29287525120be2953b76881ba3cfc4379c265e7a
ToppCell	facs-Skin-nan-18m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 LAMA2 LAMA4 ADAM33 SP110 SVEP1	1.18e-06	189	80	6	7150dad9a92a715487c2d8130fa01b752ea69663
ToppCell	facs-Skin-nan-18m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 LAMA2 LAMA4 ADAM33 SP110 SVEP1	1.18e-06	189	80	6	6e4c0effd5192fd00052abc048fdb87a74fb6554
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.21e-06	190	80	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGBL1 FBLN2 IGFBP3 EGFR LAMA2 ITGB5	1.25e-06	191	80	6	4b50fdd310701251e64e16cd2d07ce03dbfd3e3e
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGBL1 FBLN2 IGFBP3 EGFR LAMA2 ITGB5	1.25e-06	191	80	6	75d2197076a9dfc868e8baf95bd4c5e44f438e3e
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EGFR LAMA2 LAMA4 TWSG1 ITGB5 SVEP1	1.25e-06	191	80	6	997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 SVEP1	1.29e-06	192	80	6	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 LAMA4 SVEP1	1.29e-06	192	80	6	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 LAMA2 LAMA4 TWSG1 ITGB5 SVEP1	1.33e-06	193	80	6	f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 LAMA2 LAMA4 TWSG1 ITGB5 SVEP1	1.33e-06	193	80	6	85faf6c5ce4769615a4eca036e2ba307e176bb52
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGBL1 FBLN2 EGFR LAMA2 ITGB5 SVEP1	1.33e-06	193	80	6	45b5cab4dfeb0ed3b13631db5963740a792b810f
ToppCell	facs-MAT-Fat-3m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 LAMA2 LAMA4 TWSG1 ITGB5 SVEP1	1.33e-06	193	80	6	110a7d2ba7d066c2be38be98b643b76c520dd980
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IGFBP3 EGFR LAMA2 LAMA4 TWSG1 ITGB5	1.41e-06	195	80	6	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.41e-06	195	80	6	e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.46e-06	196	80	6	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.46e-06	196	80	6	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	Control-Stromal-Fibroblast\|Control / Disease state, Lineage and Cell class	FBLN2 EGFR LAMA2 LAMA4 ADAM33 SVEP1	1.46e-06	196	80	6	7ca94477498a84cafcdd9933ee92a6cbde76c70e
ToppCell	Control-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	FBLN2 EGFR LAMA2 LAMA4 ADAM33 SVEP1	1.46e-06	196	80	6	1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.46e-06	196	80	6	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCARF1 RELN VWF LAMA4 PDGFC STAB1	1.46e-06	196	80	6	aa52f77f80c3fe23369347a34e0b3188b768a763
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 ADAM33 ITGB5 SVEP1	1.50e-06	197	80	6	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.50e-06	197	80	6	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.54e-06	198	80	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 EGFR LAMA2 LAMA4 TWSG1 ITGB5	1.54e-06	198	80	6	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SCARF1 RELN CYB5RL LAMA4 SSPOP STAB1	1.54e-06	198	80	6	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	Control-Stromal\|Control / Disease state, Lineage and Cell class	FBLN2 EGFR LAMA2 LAMA4 ADAM33 SVEP1	1.54e-06	198	80	6	ae726b6b7f0a4107899be4d32ac256ffa0bd8d59
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SCARF1 RELN CYB5RL LAMA4 SSPOP STAB1	1.54e-06	198	80	6	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	5'-Parenchyma_lung-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.54e-06	198	80	6	aae663c6da70b6e716edeed50cc7d3962d78e697
ToppCell	medial-2-Epithelial-Mucous\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ERBB3 FCGBP IGFBP3 INSR CRISP3 MUC5B	1.59e-06	199	80	6	4737250b7ffa7cc19eb6b057d35d78f13b1afe66
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.59e-06	199	80	6	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	medial-Epithelial-Mucous\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ERBB3 FCGBP IGFBP3 INSR CRISP3 MUC5B	1.59e-06	199	80	6	4385963ab25b5378e7964b984028c25b27e5794e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.59e-06	199	80	6	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.59e-06	199	80	6	fb580e9321ddf97c73b2e356cd82523db74a38a2
ToppCell	medial-Epithelial-Mucous-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ERBB3 FCGBP IGFBP3 INSR CRISP3 MUC5B	1.59e-06	199	80	6	53198bcf5f2f012a3ed1600d95c0923d6976a099
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Biopsy_Control_(H.)-Mesenchymal\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	01522ed0b68614b1ebdf190957d44a9d48a6c6e3
ToppCell	Bronchial-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	5ea12e17f50fefbf5534e487af3392b2fa2d13ad
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	17ffdbc13332bd3ed1d54abcd7af20267dd4b234
ToppCell	3'-Parenchyma_lung-Mesenchymal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	58c5870030192b337e7d883044948634fcd17d2c
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	05486d86868f6a93429226063cca270f00dd8714
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	665df8391d2ebcfc6536318612f4992852b5e2b8
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	6e3d1ae0ef84d3075afa40129a41169996462672
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	proximal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	869d45b71efd395d050873db5fee2ed0443d5e6f
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	b04831708fa20471a127b87e8db3728b6e729ce8
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	6316c288022719b9e6c4332c5cb9041e1188d0e8
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	74ad0ae592252060ee294d7483327d765a6ba1dd
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 TWSG1 ITGB5 SVEP1	1.64e-06	200	80	6	efdf7066b7dd43e35dbc0d2719b75f250cf54af2
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	7ba292c30d915e66ebc8026fa76492cedf64700e
ToppCell	Tracheal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	920e6036c0a9c0089d0d898673daf9dd9d7279fc
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGBL1 FBLN2 LAMA2 LAMA4 ADAM33 SVEP1	1.64e-06	200	80	6	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ERBB3 FCGBP WFIKKN1 MUC5B VWDE	9.74e-06	158	80	5	adad97e6cf479d42791c5ba9cbc5f15f469322bf
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 MUC5B TECTA SVEP1 CRB1	1.04e-05	160	80	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 MUC5B TECTA SVEP1 CRB1	1.04e-05	160	80	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 LAMA2 LAMA4 ADAM33 SVEP1	1.31e-05	168	80	5	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 LAMA2 LAMA4 ADAM33 SVEP1	1.43e-05	171	80	5	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SCARF1 VWF WTIP CAMK1G MEGF11	1.47e-05	172	80	5	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERBB3 FCGBP INSR CRISP3 MUC5B	1.47e-05	172	80	5	63a91974b12c3f7f0c6bf66c30088d7fc07f5cea
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF OTOGL ADAM33 PDGFC STAB1	1.47e-05	172	80	5	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF OTOGL ADAM33 PDGFC STAB1	1.47e-05	172	80	5	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCARF1 RELN CYB5RL LAMA4 PDGFC	1.51e-05	173	80	5	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EGFR ADAM33 VWDE SVEP1 EGFEM1P	1.60e-05	175	80	5	e78bf0c33a741bb97e987e41ac33da9e623a08ec
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGBL1 LAMA2 LAMA4 ADAM33 SVEP1	1.60e-05	175	80	5	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 EGFR LAMA2 LAMA4 SVEP1	1.64e-05	176	80	5	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 EGFR LAMA2 LAMA4 SVEP1	1.64e-05	176	80	5	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
Computational	Adhesion molecules.	ITGBL1 RELN VWF LAMA2 LAMA4 ITGB2 ITGB5	8.92e-07	141	41	7	MODULE_122
Computational	Trachea genes.	ERBB3 FBLN2 FCGBP VWF IGFBP3 EGFR MUC5B ITGB5 STAB1	2.04e-05	415	41	9	MODULE_6
Computational	Genes in the cancer module 275.	ITGB2 ITGB5 ITGB6	2.79e-05	16	41	3	MODULE_275
Computational	Heart, liver, kidney and pancreas metabolic and xenobiotic response genes.	ERBB3 FBLN2 FCGBP VWF IGFBP3 EGFR TM4SF4 MUC5B C8B ITGB5 STAB1	2.11e-04	835	41	11	MODULE_88
Computational	Placenta genes.	ERBB3 FBLN2 FCGBP VWF IGFBP3 EGFR ITGB5 STAB1	3.04e-04	463	41	8	MODULE_38
Computational	DRG (dorsal root ganglia) genes.	ERBB3 FBLN2 VWF IGFBP3 LAMA4 ITGB5 STAB1	5.53e-04	384	41	7	MODULE_2
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ITGBL1 IGFBP3 ITGB5	8.91e-04	50	41	3	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8
Computational	Genes upregulated in subsets of cells of a given type within various tumors	IGFBP3 INSR LAMA4	8.91e-04	50	41	3	GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1
Computational	Genes in the cancer module 412.	ITGB2 ITGB5	1.08e-03	13	41	2	MODULE_412
Computational	Liver genes - metabolism and xenobiotics.	ITGBL1 ERBB3 IGFBP3 EGFR TM4SF4 C8B ITGB5 STAB1	1.11e-03	563	41	8	MODULE_23
Drug	Mecasermin	IGF1R IGFBP3 INSR	3.87e-08	3	78	3	DB01277
Drug	oxypertine	ITGBL1 RELN VWF ITGB2 ITGB6	7.02e-07	49	78	5	CID000004640
Drug	Folfox protocol	ERBB3 IGF1R EGFR	2.14e-06	8	78	3	ctd:C410216
Drug	N-acetylhexosamine	ERBB3 IGF1R VWF EGFR INSR ADAM33 ITGB2 ITGB5 ITGB6 STAB1	4.76e-06	472	78	10	CID000000899
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A	SCARF1 ITGBL1 ERBB3 IGF1R IGFBP3 KRTAP9-9 SVEP1	4.96e-06	196	78	7	3042_UP
Drug	BE-23372M	ERBB3 EGFR INSR	6.26e-06	11	78	3	CID005311105
Drug	Grgds	FBLN2 VWF LAMA4 ITGB2 ITGB5	9.76e-06	83	78	5	CID000123811
Drug	Insulin Glargine	IGF1R INSR	1.16e-05	2	78	2	ctd:D000069036
Drug	Insulin Lispro	IGF1R INSR	1.16e-05	2	78	2	DB00046
Drug	Insulin Glargine	IGF1R INSR	1.16e-05	2	78	2	DB00047
Drug	AC1L1KDK	EGFR INSR	1.16e-05	2	78	2	CID000005451
Drug	4-anilinoquinazoline	ERBB3 EGFR INSR	2.10e-05	16	78	3	CID000324081
Drug	2-acetamidoethanethiol	ERBB3 EGFR	3.47e-05	3	78	2	ctd:C023704
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A	RELN MEGF6 INSR LAMA4 MUC5B SVEP1	5.79e-05	196	78	6	5606_UP
Drug	estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A	SCARF1 CRISP2 LRP12 EGFR LAMA2 KRTAP9-9	5.95e-05	197	78	6	4465_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ZNF821 IGF1R INSR LAMA4 ITGB6 CRB1	5.95e-05	197	78	6	5605_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	CRISP2 NELL2 CYB5RL EGFR SVEP1 STAB1	6.29e-05	199	78	6	6357_UP
Drug	AC1L1GKK	IGF1R INSR	6.92e-05	4	78	2	CID000003725
Drug	PD168393	ERBB3 EGFR	6.92e-05	4	78	2	CID000004708
Drug	EGFR/ErbB2 inhibitor	VWF EGFR	6.92e-05	4	78	2	CID009843206
Drug	LMWH	SCARF1 LRP12 ERBB3 FBLN2 VWF OXT IGFBP3 EGFR LAMA2 LAMA4	8.66e-05	663	78	10	CID000000772
Drug	iodide	SCARF1 LRP12 IGF1R VWF OXT IGFBP3 EGFR INSR SERINC5	8.70e-05	534	78	9	CID000024841
Drug	Mifepristone	ITGBL1 ERBB3 VWF OXT IGFBP3 EGFR LAMA2 SERINC5 SVEP1	1.13e-04	553	78	9	ctd:D015735
Drug	3-quinolinecarbonitrile	IGF1R EGFR	1.15e-04	5	78	2	CID000093177
Drug	PQ401	IGF1R INSR	1.15e-04	5	78	2	CID009549305
Drug	RG 14921	ERBB3 EGFR	1.15e-04	5	78	2	CID000197517
Drug	6-quinolinecarbaldehyde	ERBB3 EGFR	1.15e-04	5	78	2	CID000765653
Drug	trypanothione disulfide	LAMA4 SERINC5 ITGB2 ITGB5 ITGB6	1.20e-04	140	78	5	CID000115098
Drug	AC1L1O6Q	ERBB3 EGFR INSR NFX1 ITGB2	1.25e-04	141	78	5	CID000058035
Disease	level of cysteine-rich secretory protein 2 in blood serum	CRISP2 CRISP3	5.71e-06	2	71	2	OBA_2041144
Disease	gestational diabetes (biomarker_via_orthology)	IGF1R INSR	5.68e-05	5	71	2	DOID:11714 (biomarker_via_orthology)
Disease	cortical thickness	ERBB3 NELL2 RELN CNNM2 IGF1R IGFBP3 EGFR LAMA2 PDGFC ITGB5 STAB1	6.74e-05	1113	71	11	EFO_0004840
Disease	Early Pregnancy Loss	IGFBP3 LAMA4 CRISP3 ITGB6	1.41e-04	109	71	4	C3830362
Disease	Miscarriage	IGFBP3 LAMA4 CRISP3 ITGB6	1.41e-04	109	71	4	C4552766
Disease	Spontaneous abortion	IGFBP3 LAMA4 CRISP3 ITGB6	1.41e-04	109	71	4	C0000786
Disease	Abortion, Tubal	IGFBP3 LAMA4 CRISP3 ITGB6	1.41e-04	109	71	4	C0000822
Disease	cysteine-rich secretory protein 2 measurement	CRISP2 CRISP3	1.58e-04	8	71	2	EFO_0801511
Disease	high grade glioma (implicated_via_orthology)	IGF1R EGFR INSR	1.65e-04	44	71	3	DOID:3070 (implicated_via_orthology)
Disease	schizophrenia (is_marker_for)	RELN VWF EGFR	1.65e-04	44	71	3	DOID:5419 (is_marker_for)
Disease	reticulocyte count	SCARF1 ATRN CRISP2 CNNM2 VWF INSR LAMA4 ADAM33 PDGFC ACAP2	1.93e-04	1045	71	10	EFO_0007986
Disease	alcohol dependence (implicated_via_orthology)	IGF1R INSR	2.03e-04	9	71	2	DOID:0050741 (implicated_via_orthology)
Disease	Head and Neck Carcinoma	ERBB3 EGFR	2.54e-04	10	71	2	C3887461
Disease	retinal drusen	VWF SVEP1 EGFEM1P	2.56e-04	51	71	3	EFO_1001155
Disease	renal cell carcinoma (is_marker_for)	VWF IGFBP3 EGFR INSR	2.62e-04	128	71	4	DOID:4450 (is_marker_for)
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	IGF1R C8B ITGB5 STAB1	2.86e-04	131	71	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	IGF1R C8B ITGB5 STAB1	2.86e-04	131	71	4	C4552091
Disease	Juvenile arthritis	IGF1R C8B ITGB5 STAB1	2.86e-04	131	71	4	C3495559
Disease	Juvenile psoriatic arthritis	IGF1R C8B ITGB5 STAB1	2.86e-04	131	71	4	C3714758
Disease	sleep disorder (implicated_via_orthology)	IGF1R INSR	3.10e-04	11	71	2	DOID:535 (implicated_via_orthology)
Disease	gallbladder neoplasm	ERBB3 EGFR	3.10e-04	11	71	2	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB3 EGFR	3.10e-04	11	71	2	C0153452
Disease	Juvenile-Onset Still Disease	IGF1R C8B ITGB5 STAB1	3.21e-04	135	71	4	C0087031
Disease	Vertigo	LRP12 OTOGL TECTA OTOG	3.59e-04	139	71	4	HP_0002321
Disease	Bladder Neoplasm	ERBB3 IGFBP3 EGFR LAMA2	3.69e-04	140	71	4	C0005695
Disease	Malignant neoplasm of urinary bladder	ERBB3 IGFBP3 EGFR LAMA2	3.79e-04	141	71	4	C0005684
Disease	median neuropathy (biomarker_via_orthology)	ERBB3 EGFR	5.10e-04	14	71	2	DOID:571 (biomarker_via_orthology)
Disease	diabetic neuropathy (implicated_via_orthology)	IGF1R INSR	5.10e-04	14	71	2	DOID:9743 (implicated_via_orthology)
Disease	Dermatitis	EGFR ITGB2	6.70e-04	16	71	2	C0011603
Disease	pre-malignant neoplasm (biomarker_via_orthology)	SUV39H1 INSR	7.58e-04	17	71	2	DOID:0060071 (biomarker_via_orthology)
Disease	erythritol measurement	TMEM275 ITGB6	7.58e-04	17	71	2	EFO_0021171
Disease	response to alcohol	LRP12 EGFR LAMA2	7.96e-04	75	71	3	EFO_0005526
Disease	Adrenocortical carcinoma	IGF1R EGFR	8.52e-04	18	71	2	C0206686
Disease	Congenital hernia of foramen of Morgagni	IGF1R INSR	9.51e-04	19	71	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	IGF1R INSR	9.51e-04	19	71	2	C0265700
Disease	type 1 diabetes mellitus (biomarker_via_orthology)	VWF EGFR	9.51e-04	19	71	2	DOID:9744 (biomarker_via_orthology)
Disease	inflammatory bowel disease (is_implicated_in)	IGFBP3 EGFR	9.51e-04	19	71	2	DOID:0050589 (is_implicated_in)
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB3 EGFR	9.51e-04	19	71	2	DOID:2876 (is_marker_for)
Disease	bipolar disorder (is_marker_for)	RELN VWF	9.51e-04	19	71	2	DOID:3312 (is_marker_for)
Disease	Nonsyndromic Deafness	OTOGL TECTA OTOG	9.96e-04	81	71	3	C3711374
Disease	Hodgkins lymphoma	FCGBP MEGF11 STAB1	1.03e-03	82	71	3	EFO_0000183
Disease	liver cirrhosis (is_marker_for)	RELN EGFR ITGB6	1.03e-03	82	71	3	DOID:5082 (is_marker_for)
Disease	breast cancer (is_marker_for)	IGF1R IGFBP3 EGFR INSR	1.05e-03	185	71	4	DOID:1612 (is_marker_for)
Disease	prostate adenocarcinoma (is_implicated_in)	IGF1R INSR	1.05e-03	20	71	2	DOID:2526 (is_implicated_in)
Disease	Malignant neoplasm of breast	ERBB3 IGF1R VWF EGFR OTOGL LAMA2 ADAM33 TECTA SP110	1.07e-03	1074	71	9	C0006142
Disease	Congenital diaphragmatic hernia	IGF1R INSR	1.16e-03	21	71	2	C0235833
Disease	Lewy Body Disease	IGF1R INSR	1.28e-03	22	71	2	C0752347
Disease	Down syndrome (is_marker_for)	RELN IGFBP3	1.28e-03	22	71	2	DOID:14250 (is_marker_for)
Disease	cortical surface area measurement	ERBB3 RELN CNNM2 MEGF6 EGFR LAMA2 TWSG1 PDGFC ITGB5 SVEP1	1.37e-03	1345	71	10	EFO_0010736
Disease	Acute Confusional Senile Dementia	RELN IGF1R INSR	1.77e-03	99	71	3	C0546126
Disease	Alzheimer's Disease, Focal Onset	RELN IGF1R INSR	1.77e-03	99	71	3	C0750900
Disease	Alzheimer Disease, Early Onset	RELN IGF1R INSR	1.77e-03	99	71	3	C0750901
Disease	Presenile dementia	RELN IGF1R INSR	1.77e-03	99	71	3	C0011265
Disease	Alzheimer Disease, Late Onset	RELN IGF1R INSR	1.77e-03	99	71	3	C0494463
Disease	diabetes mellitus (implicated_via_orthology)	IGF1R INSR	1.79e-03	26	71	2	DOID:9351 (implicated_via_orthology)
Disease	Familial Alzheimer Disease (FAD)	RELN IGF1R INSR	1.83e-03	100	71	3	C0276496
Disease	Alzheimer's Disease	RELN IGF1R INSR	1.88e-03	101	71	3	C0002395
Disease	glucose metabolism disease (implicated_via_orthology)	IGF1R INSR	2.07e-03	28	71	2	DOID:4194 (implicated_via_orthology)
Disease	chronic obstructive pulmonary disease (biomarker_via_orthology)	ERBB3 EGFR	2.07e-03	28	71	2	DOID:3083 (biomarker_via_orthology)
Disease	hypertension (biomarker_via_orthology)	IGF1R VWF OXT EGFR	2.21e-03	227	71	4	DOID:10763 (biomarker_via_orthology)
Disease	urinary bladder cancer (is_marker_for)	ERBB3 IGFBP3 EGFR	2.22e-03	107	71	3	DOID:11054 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QELCQCRPGEGNCSC	TWSG1	41	Q9GZX9
PNPNQCCHDECAGGC	ERBB3	221	P21860
CDCGPGQECRDLCCF	ADAM33	431	Q9BZ11
DCGTEAQCGPASCCD	ADAM32	406	Q8TC27
QCIPGNASCCDCGLA	ACAP2	406	Q15057
TCCLGPSGGLNCDCC	C22orf42	6	Q6IC83
GCPDDCDKGLCTNSC	CRISP2	191	P16562
LKQIPNSCVSGCCCG	DCAF16	166	Q9NXF7
QCCGECVQTACLTPD	MUC5B	5581	Q9HC84
GGNCACCLHNCNECQ	PDGFC	281	Q9NRA1
AHCELRCPCQNGGTC	MEGF11	226	A6BM72
DGCQLPCTCQNGADC	MEGF11	401	A6BM72
CGCCWECANLEGQLC	KAZALD1	76	Q96I82
CACDQFRCGNGKCIP	LRP12	166	Q9Y561
CCPLGCAKCAQGCIR	MT1HL1	36	P0DM35
NGGACIAANVCACPQ	NELL2	531	Q99435
PCNNDFCRLGCVCSS	MGA	1046	Q8IWI9
CQPCKCNGHASLCNT	ATRN	1106	O75882
ENNECCHPECLGSCS	IGF1R	226	P08069
PGACCATCVQQGCAC	FBLN2	51	P98095
DCVCGKCVCTNPGAS	ITGB6	596	P18564
SQCCGSGCSPCVFDL	CYB5RL	26	Q6IPT4
CAELCHGGQCQPCQI	NFX1	511	Q12986
CGSVCSDQGCGLENC	KRTAP4-12	6	Q9BQ66
SDQGCGLENCCRPSC	KRTAP4-12	11	Q9BQ66
CGSVCSDQGCDQGLC	KRTAP4-1	6	Q9BYQ7
CGSVCSDQGCGLENC	KRTAP4-2	6	Q9BYR5
SDQGCGLENCCRPSC	KRTAP4-2	11	Q9BYR5
GQGLGQESCCRPSCC	KRTAP4-3	16	Q9BYR4
CGSVCSDQGCGLENC	KRTAP4-4	6	Q9BYR3
CTACECSHLGNNCDP	LAMA2	1011	P24043
EGLCCHSECLGNCSQ	INSR	231	P06213
GHCLCGQCQCTEPGA	ITGB5	606	P18084
CNGQGSCINGTKCIC	RELN	2136	P78509
LAAGPCGCCSSCLNI	CAMK1G	411	Q96NX5
CSGLGDCVCGQCLCH	ITGB2	506	P05107
CCHNQCAAGCTGPRE	EGFR	231	P00533
CKLQPGANCSIGLCC	ADAM30	431	Q9UKF2
CASCPDNCDDGLCTN	CRISP3	191	P54108
GALCCCICDPGVNVV	BTAF1	686	O14981
PLQCPDGCAEGCQCD	FCGBP	2756	Q9Y6R7
APLQCPDGCAEGCQC	FCGBP	3956	Q9Y6R7
CCCCLANVSLPGIGG	DENND11	276	A4D1U4
SDQGCGLETCCRPSC	KRTAP4-6	11	Q9BYQ5
CGSVCSDQGCSQDLC	KRTAP4-7	6	Q9BYR0
CGSVCSDQGCGQDLC	KRTAP4-8	6	Q9BYQ9
CGSVCSDQGCGQDLC	KRTAP4-9	6	Q9BYQ8
VCLPGCLNQSCGSNC	KRTAP9-2	126	Q9BYQ4
VCLPGCLNQSCGSNC	KRTAP9-3	111	Q9BYQ3
VCLPGCLNQSCGSNC	KRTAP9-4	111	Q9BYQ2
VCLPGCLNQSCGSSC	KRTAP9-6	126	A8MVA2
VCLPGCLNQSCGSNC	KRTAP9-8	111	Q9BYQ0
VCLPGCLNQSCGSSC	KRTAP9-9	106	Q9BYP9
GQSVCCDAGSCQPSC	KRTAP29-1	146	A8MX34
CASDPCVNGGLCQDL	CRB1	1301	P82279
CSCPAGCRVILCNEN	EGFEM1P	41	Q0D2K5
LICTGNGICSCGNCE	ITGBL1	461	O95965
CDCICPVGSQGLACE	C8B	521	P07358
NCNLGGDCECLCTSI	OTOGL	1166	Q3ZCN5
KNCAVCNCGGGPCDS	LAMA4	236	Q16363
NCLTDTCGCSQGGDC	OTOG	1196	Q6ZRI0
GCGCCLTCALSEGQP	IGFBP3	66	P17936
GCQEICPACQHAARC	MEGF6	781	O75095
PGCEQRCQCQHGAAC	MEGF6	911	O75095
AACDAVNGSCLCPAG	MEGF6	966	O75095
PNCTHVCGCGQGAAC	MEGF6	1256	O75095
TKQYCCDGCWPNGCC	SPRING1	111	Q9H741
CAQALCPAECAVGGD	SSPOP	556	A2VEC9
CGELGSCVAGCNCPL	SSPOP	851	A2VEC9
PCENCSCVSGLIANC	SSPOP	3161	A2VEC9
RCFGPNICCAEELGC	OXT	51	P01178
EQPCGLGCLVSTCCE	SLCO6A1	86	Q86UG4
ECEVCCQGGQLLCCG	SP110	536	Q9HB58
CQNGGICQRPNACSC	SVEP1	3476	Q4LDE5
GNNCSVPCECPEGLC	SCARF1	391	Q14162
CECQDCLWAPTGGCC	SUV39H1	181	O43463
LLLLSCCCGAGGCAA	CNNM2	51	Q9H8M5
GPICVDSCSEGCQCD	TECTA	1006	O75443
CQHGGTCLAGNLCTC	VWDE	1366	Q8N2E2
CQERCVDGCSCPEGQ	VWF	321	P04275
CAGQLACCCGSAGCS	SERINC5	6	Q86VE9
GPNCTGVCDCAHGLC	STAB1	1376	Q9NY15
LCCACGLCALLAGVN	TMEM275	31	A0A0U1RQS6
ACQQACARGPGDACV	WFIKKN1	346	Q96NZ8
ELCQCPLCQLDCGSR	ZNF821	116	O75541
PGCFRCSVCNECLDG	WTIP	311	A6NIX2
VCDLTPGACDINCCC	TCTN3	91	Q6NUS6
PFCCGECGRAFVQQC	ZNF425	301	Q6IV72
ADICQCCNKGDCGTP	ZP3	316	P21754
GLLGTLCGDCQCCGC	TM4SF4	181	P48230